BioCentury
ARTICLE | Financial News

Fate completes private placement

November 22, 2016 11:38 PM UTC

Fate raised $57 million in a private placement through the sale of 2.8 million preferred shares at $13.30 to Redmile Group LLC and 7.2 million shares of common stock at $2.66 to BVF Partners L.P., Eco...

BCIQ Company Profiles

Fate Therapeutics Inc.